Navigation Links
Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
Date:2/7/2013

5 million people globally suffer from Parkinson's disease, a neurodegenerative disorder caused by the diminished production of dopamine, a key neurotransmitter, resulting in progressive impairment of motor function including tremors, rigidity and difficulty in moving. Long-term treatment of Parkinson's disease (PD) patients with levodopa, also called L-dopa, typically leads to unwanted side effects including L-dopa induced dyskinesia (LID), which prevents optimal treatment of the disease.

L-dopa Induced Dyskinesia
Levodopa, also called L-dopa, is the most commonly administered drug to treat Parkinson's symptoms. L-dopa helps restore levels of dopamine, a chemical messenger in the brain responsible for smooth, coordinated movement and other motor and cognitive functions. Dyskinesia is a common side effect of L-dopa treatment. These involuntary, uncontrollable, and often excessive movements are distinct from the rhythmic tremor commonly associated with Parkinson's disease.

About Metabolic Solutions Development Company
Metabolic Solutions Development Company (www.msdrx.com) is a drug discovery and development company investigating novel molecular targets and developing new therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially type 2 diabetes.

About The Michael J. Fox Foundation for Parkinson's Research
As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $313 million in research to date, the Foundation has fundamenta
'/>"/>

SOURCE Metabolic Solutions Development Company, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Metabolic Solutions Development Company announces publication of Phase 2b data in Clinical Pharmacology & Therapeutics
2. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
3. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
4. Profil Institute Partners with Florida Hospital to Establish East Coast Center for Clinical Metabolic Research
5. New Wellness Products with Results that Identify Healthiness, Deficiencies and Solutions
6. H. D. Smith Specialty Solutions Appoints 20-year Industry Veteran Tim Booth To Executive Vice President, Smith Medical Partners
7. BioLife Solutions Appoints Rick Stewart To Board of Directors
8. New Findings Offer Systemic Solutions to Address Non-communicable Diseases (NCDs) in Low- and Middle-income Countries
9. Omnicell to Showcase Automation Solutions at Arab Health 2013
10. Elekta to Showcase Broad Portfolio of Cancer Management Solutions at 2013 Arab Health Congress and Exhibition
11. H. D. Smith Establishes Specialty Solutions Organization And Realigns Senior Leadership To Support Growing Geographic Reach, Diversified Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... VANCOUVER, British Columbia , March 5, 2015 ... BMKDF) -- The ultimate goal in the cancer diagnostics ... of detecting tumors before they become disruptive, metastatic and ... such an assay has been the holy grail ... many breakthrough diagnostics have been invented such as ELISA-based ...
(Date:3/4/2015)... 4, 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... of the Phase II proof of concept clinical ... as a monotherapy in the treatment of chronic ... highly significant and clinically meaningful improvement from baseline ... measured on a 100mm unit Visual Analog Scale ...
(Date:3/4/2015)... 4, 2015 GSI Group Inc. (NASDAQ: ... global leader and supplier of precision photonics and motion ... advanced industrial technology markets, today reported financial results for ... noted, all financial results in this press release are ... QuarterDuring the fourth quarter of 2014, GSI generated revenue ...
Breaking Medicine Technology:New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 16GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 17GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 18GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 19GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 20GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 21GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 23GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 24GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 25GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 26GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 27
... Isotopes Inc (OTC Bulletin Board: INIS ) announces ... general business status, particularly, the year to date performance of ... of its ongoing plans for the depleted uranium de-conversion project. ... When: Wednesday, September 14 – 3:00PM ...
... 2011 The Educational Review System announces the pediatric ... Gaps — Where do we go from here?" – ... first annual Pediatric Medication Safety Summit, will focus on ... benefits of technology and the gaps. ...
Cached Medicine Technology:International Isotopes Inc Announces Conference Call to Give an Update on the Company's General Business Status 2
(Date:3/5/2015)... IL (PRWEB) March 05, 2015 The ... announce their sponsorship of the upcoming Crain’s Chicago Business ... , The Physicians' Breakfast will take place from 7:30 ... East Pearson Street, Chicago, IL 60611. The morning’s events ... Chicago’s top healthcare professionals. , The panel discussion ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Colorful packaging ... breakfast cereals are best for health. But all it ... what to look for, reports the March 2015 ... a plan," says Kathy McManus, director of the Department ... for a cereal that hits all the markers of ...
(Date:3/5/2015)... 2015 Considering egg freezing? Atlanta Center ... holding an informational event on March 30, ... future families with egg freezing. , What: Egg Freezing ... Rd, Atlanta, GA, Time: 5:30 - 7:30 PM, Date: ... Register here ! , In response to the ...
(Date:3/5/2015)... Plains, NY (PRWEB) March 05, 2015 Hope ... New York Sporting Clay Shoot to be held at Beretta ... May 15, 2015. All proceeds from the event will benefit ... a sense of self, restoring the family unit, and restoring ... The event will honor our nation’s heroes through a day ...
(Date:3/5/2015)... NE (PRWEB) March 05, 2015 Aureus ... staffing, including locum tenens and direct hire physician jobs, ... at the Nebraska Academy of Family Physicians 67th Annual ... 2015 in La Vista, Nebraska. , The Annual ... ways to learn, networking opportunities, and an exhibition of ...
Breaking Medicine News(10 mins):Health News:Cook County Law Firm to Sponsor Physicians Breakfast 2Health News:Tips to Find the Healthiest Breakfast Cereals, From the March 2015 Harvard Health Letter 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 3Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2Health News:Healthcare Staffing Agency, Aureus Medical Group, to Exhibit at the Nebraska Academy of Family Physicians Annual Meeting & Scientific Assembly 2
... WORTH, Texas, April 21 A company known for,standing ... a step toward,saving the lives of premature babies over ... the Tarrant County effort,to support the 2008 March of ... The March for Babies is a nationwide campaign that ...
... not everyone who is bitten by a malaria-infected mosquito ... the University of Toronto. , Malaria causes an estimated ... headache, high fevers and nausea to more than 1 ... a major effect on the evolution of our species. ...
... Fund Corp.,(OTC:MXFD), is pleased to announce that Mr. Dan ... been appointed to the Board of Directors of,the Company., ... Mr. Schmitt brings with,him, his vast experience and entrepreneurial ... board members since September 2007, we,are very pleased that ...
... wonder giving relief to ... incontinence patients worldwide, DETROIT, April 21 ... new agreement with HANMEDICS, a,Korea-based medical device company recognized for ... their first glimpse of the,"wonder-machine," acclaimed world-wide, known as the ...
... French . , Montreal, April 21, ... cells communicate has just been discovered by the team ... the McGill University Health Centre (MUHC) in collaboration with ... cells are able to communicate with their more healthy ...
... to Speak, CLEVELAND, April 21 Recovery Resources ... and drug,addiction agencies, will hold its 2008 Annual Meeting ... Windows on the River in the Powerhouse Building,in the ... of,Children,s Programs at the Betty Ford Center. His address ...
Cached Medicine News:Health News:MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors 2Health News:MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors 3Health News:Medical Breakthrough Reaches America 2Health News:Cancer cells spread by releasing 'bubbles', according to an MUHC study 2Health News:Focus on Children of Alcoholics at Addiction Agency's Annual Meeting 2
Engineered for high volume surgical efficiencies, the Bausch & Lomb Hansatome Microkeratome, a corneal resection instrument, features an automated pivoting motion that provides smooth, resistance-fre...
... The Brilliance 64-channel configuration breaks through ... large volume, thin-slice coverage to improve ... , ,With 40mm of thin-slice coverage, ... imaging, allowing for unprecedented coronary artery ...
Assay for Anti-HTLV-I and Anti-HTLV-II...
InBios' Trypanosoma cruzi (chagas disease) is an ELISA system for the detection of antibodies to T.cruzi derived TcF antigen in human serum or plasma This test is intended for professional in vitro d...
Medicine Products: